Breast Cancer Research Program Archives

Exteriors of the UNC Lineberger and Marsico Hall buildings

The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.

Patient in a hospital bed holds their caregiver's hand

A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.

A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.

Lisa M. Carey, MD, ScM, FASCO, Charles M. Perou, PhD, and Aranzazu Fernandez-Martinez, MD, PhD

Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.

Charles Perou, PhD, presented the 2022 AACR Distinguished Lectureship in Breast Cancer Research at the 45th San Antonio Breast Cancer Symposium.

Tag: Breast Cancer Research Program

Office of Graduate Education recognizes four Lineberger members with mentorship awards

Oncology Times: 3 Questions on… Addressing Disparities in Breast Cancer Treatment Delays

OncLive: Dr. Carey on the Response-Guided Therapy in HER2+ Breast Cancer

Race and geography linked to different risks of breast cancer treatment delays

Study identifies molecular differences between primary breast cancer and its metastases

ASCO Post: Immune System B Cells May Help to Predict Treatment Response Among Patients With HER2-Positive Breast Cancer

Precision Oncology News: Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses

Medscape: Agents and Sequencing Decisions for HR+ Breast Cancer

Immune system B-cells can help predict HER2-positive breast cancer treatment response

Perou presents AACR Distinguished Lectureship in Breast Cancer Research